Your browser doesn't support javascript.
loading
LINC02875 Upregulation Contributed to Poor Prognosis for the Hepatocellular Carcinoma and Progression for the Cancerous Cells.
Liu, Yujian; Yang, Jingrui; Ke, Rui-Sheng; Wu, Lupeng; Hong, Zaifa; Guo, Ping; Feng, Liuxing; Li, Zhimin.
Afiliación
  • Liu Y; Department of Hepatobiliary Pancreatic Vascular Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Yang J; Department of Hepatobiliary Pancreatic Vascular Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Ke RS; Department of General Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Wu L; Department of Hepatobiliary Pancreatic Vascular Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Hong Z; Department of Hepatobiliary Pancreatic Vascular Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Guo P; Department of Hepatobiliary Pancreatic Vascular Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Feng L; Department of Hepatobiliary Pancreatic Vascular Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Li Z; Department of Hepatobiliary Pancreatic Vascular Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Horm Metab Res ; 54(11): 760-767, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36055279

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / MicroARNs / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Horm Metab Res Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / MicroARNs / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Horm Metab Res Año: 2022 Tipo del documento: Article País de afiliación: China